DIN 02492393 — TECENTRIQ 840 MG
TECENTRIQ is a solution of Atezolizumab marketed by HOFFMANN-LA ROCHE LIMITED. The full Atezolizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02492393
- Brand name
- TECENTRIQ
- Active ingredient
- Atezolizumab
- Strength
- 840 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Anti-PD-L1 monoclonal antibody (immune checkpoint inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Atezolizumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02462990 | TECENTRIQ | 1200 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02546310 | TECENTRIQ SC | 125 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |